Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial

CONCLUSION: This crossover clinical trial demonstrated that in the course of DME treatment with IVB injections, topical ketorolac did not have any additive beneficial effect at least during a six-week period.PMID:38638629 | PMC:PMC11022031 | DOI:10.18502/jovr.v19i1.15424
Source: Journal of Ophthalmic and Vision Research - Category: Opthalmology Authors: Source Type: research